CTIS2024-514602-31-00Active, not recruitingPhase 1
ong-term aspirin therapy as a predictor of decreased susceptibility to SARSCoV-2 infection in aspirin-exacerbated respiratory disease - AERD-COV19
niwersytet Jagiellonski Collegium Medicum0 sites76 target enrollmentStarted: May 24, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 76
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 65+ (—)
- Sex
- All
Inclusion Criteria
- •INCLUSION CRITERIA FOR AERD PATIENTS:* signed informed consent form * 18-70 years old AERD patients with baseline FEV1 of at least 70% of the predicted value on the challenge/desensitization day * no pregnancy, higly effective contraception must be used, INCLUSION CRITERIA FOR HEALTHY CONTROL: * signed informed consent form * 18-70 years old and healthy condition * no asthma
Exclusion Criteria
- •failure of the circulatory and respiratory system, liver, kidneys and other vital organs, diabetes, cancer, systemic diseases of connective tissue, infectious diseases, coagulation disorders, active peptic ulcer disease, any active bleeding process., Use of drugs that interact with aspirin, use of intoxicants, alcohol abuse, active and passive smoking, pregnancy, lactation, hypersensitivity to the active substance or any of the excipients
Investigators
Similar Trials
Completed
Phase 3
The use of low-dose aspirin for the prevention of hypertensive disorders of pregnancy in a Sub-Saharan countryPrevention of hypertensive disorders of pregnancy, in particular, pre-eclampsiaPregnancy and ChildbirthISRCTN43031232niversity of KwaZulu-Natal423
Completed
Not Applicable
The influence of low dose aspirin therapy on perioperative primary haemostasis in patients with vascular disease undergoing orthopaedic surgeryHaemostasisHaematological DisordersOther coagulation defectsISRCTN11165766Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)100
Completed
Phase 2
Efficiency of low dose aspirin for prevention of complications for in vitro fertilization cycles of the patient with polycystic ovarian syndromepolycystic ovarian syndrome.Polycystic ovarian syndromeIRCT201105216541N1Infertility research center, Shiraz university of Medical Sciences80
Completed
Phase 3
The effect of Low-dose Aspirin in the Prevention of Gastric CancerGastric Cancer.Malignant neoplasm of stomachIRCT201105082032N3Ministry of Health and Medical Education21,000
Recruiting
Phase 3
The effect of low-dose aspirin on the success rate of ovulation induction in women with polycystic ovary syndromeIRCT20221112056477N1Sanandaj University of Medical Sciences120